Contact Lens Care
Pipeline by Development Stage
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 21 trials with date data
Clinical Trials (21)
Total enrollment: 2,254 patients across 21 trials
Effect of Contact Lens Wear on Immune Cell Density and Morphology of the Ocular Surface
Clinical Characterization of an Investigational Frequent Replacement Daily Wear Silicone Hydrogel Sphere Contact Lens
Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan
Silicone Hydrogel Contact Lens Clinical and Comfort Benefits With a Multi-Purpose Disinfecting Solution
Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues
Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)
Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal Epithelium
Clinical Evaluation of the Causes of Contact Lens Related Dry Eye
A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses
Two Phase Clinical Study of the Impact of Contact Lenses and Solutions on Corneal Structure
A Multi-Center Investigation of Patient Acceptability of OPTI-FREE RepleniSH® Multi-Purpose Disinfecting Solution (MPDS)
Objective Testing of Tear Film Stability
Comparison of 3 Novel Contact Lens Solutions on the Basal Lamina
Evaluation of Disinfecting Solutions and Protein Remover With a Silicone Hydrogel Lens
Corneal Barrier Function With Multi-Purpose Solutions
Effect of Multi-Purpose Solutions on Ex-Vivo Wetting Angles
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact Lenses
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact Lenses
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.